No Job Openings Found For GeneThera
Interview Tip
-
BioWorld Today August 18, 2008 [BioWorld Today](18 Aug 2008 00:01:00 EDT)UK-based Oxford BioMedica Plc. said its board unanimously rejected an offer from GeneThera Inc. to buy the company for £188 million, at a price of 35 pence per share. The price represents about a 300 percent premium over the value of Oxford Biomedica's share price of 8.65 pence at closing Aug. 14. Wheat Ridge, Colo.-based GeneThera's bid caused a 19 percent spike in the UK biotech's stock.
-
BioWorld Today August 15, 2008 [BioWorld Today](15 Aug 2008 00:01:00 EDT)The flurry of merger and acquisition activity this year has been targeted mostly at U.S. companies, but their European brethren aren't being overlooked, now including London-based Protherics plc. While U.S. biotechs have been takeout targets in the wake of a weakened dollar, European biotechs may be drawing attention for their own set of reasons.
